Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE653350DpriorityCriticalpatent/BE653350A/fr
Application filedfiledCritical
Priority to FR989236Aprioritypatent/FR88809E/fr
Application grantedgrantedCritical
Publication of FR88809EpublicationCriticalpatent/FR88809E/fr
C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07J—STEROIDS
C07J75/00—Processes for the preparation of steroids in general
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Health & Medical Sciences
(AREA)
General Health & Medical Sciences
(AREA)
Steroid Compounds
(AREA)
FR989236A1964-09-241964-09-24Composés stéroïdes dérivant de l'oestrone et de l'oestradiol et leurs procédésde préparation
ExpiredFR88809E
(fr)
Médicament a base de 17-acétate de la 6 alpha-méthyl-9 alpha-fluoro-11 béta, 17 alpha-dihydroxy-1,4-prégnadiene-3,20-dione pour le traitement de l'aménorrhée.